Big Pharma

See the following -

This Little-Known Firm Is Getting Rich Off Your Medical Data

Adam Tanner | Fortune | February 9, 2016

You may never have heard of it, but IMS Health knows an awful lot about your medical history. A global company based in Danbury, Connecticut, IMS IMS 1.58% buys bulk data from pharmacy chains such as CVS CVS 0.72% , doctor’s electronic record systems such as Allscripts, claims from insurers such as Blue Cross Blue Shield and from others who handle your health information...

Read More »

Top 10 eClinical Trends

The drug development industry is facing a revolution in the way clinical trials are being planned and conducted. It’s an industry that experiences rapid changes in technology adoption and business models, from new ways of capturing clinical data to new outsourcing strategies. This paper focuses on ten essential eClinical trends in order to help you understand which direction the biotech industry is prone to take in the next few years. As both the means, and the ultimate motivation of clinical development, patients are the most fundamental assets during the clinical trial process. We have summed up five trends that are destined to give them a more important role in the conduct of clinical studies: Boosting Patient Engagement, Integrated ePRO (electronic Patient Reported Outcomes) Systems, Mobile Clinical Studies, Personalized medicine, and Risk-based monitoring. Read More »

Why Opening Up Clinical Trials Data Is Good For Pharma Companies

Glyn Moody | TechDirt | November 5, 2013

Earlier this year we wrote about how AbbVie, the pharma company spun out of Abbott Laboratories, had gone to court to stop the European Medicines Agency (EMA) from releasing clinical trials information about one of its drugs. Read More »

You Won't Believe the Outrageous Ways Big Pharma Has Bribed Doctors to Shill Drugs

Martha Rosenberg | The Influence | July 18, 2016

At the 2010 meeting of the American Psychiatric Association in New Orleans, a psychiatrist from the East coast shared her anger with me about the recent clamp down on Pharma financial perks to doctors. Before news organizations and the 2010 Physician Financial Transparency Reports (also called the Sunshine Act, part of the Affordable Care Act) reported the outrageous amount of money Pharma was giving doctors to prescribe its new, brand-name drugs, there was almost no limit to what was spent to encourage prescribing...

Read More »

‘Subsidies Upheld, But Health Needs Still Unmet’: Doctors Group

Press Release | PNHP | June 25, 2015

Although the Supreme Court has upheld the premium subsidies under the Affordable Care Act, the law remains incapable of remedying the U.S. health crisis, physician group says

Read More »